Market Research Logo

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2016 Update

Summary

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that are designed to analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its own sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Myriad Genetics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Myriad Genetics Inc Company Overview
Myriad Genetics Inc Company Snapshot
Myriad Genetics Inc Pipeline Products and Clinical Trials Overview
Myriad Genetics Inc – Pipeline Analysis Overview
Business Description
Key Facts
Myriad Genetics Inc - Major Products and Services
Myriad Genetics Inc Pipeline Products by Development Stage
Myriad Genetics Inc Clinical Trials by Trial Status
Myriad Genetics Inc Pipeline Products Overview
BRACAnalysis CDx - Breast Cancer
BRACAnalysis CDx - Breast Cancer Product Overview
BRACAnalysis CDx - Ovarian Cancer
BRACAnalysis CDx - Ovarian Cancer Product Overview
BRACAnalysis CDx - Pancreatic Cancer
BRACAnalysis CDx - Pancreatic Cancer Product Overview
ChemoPredict Test
ChemoPredict Test Product Overview
Diagnostic Assay - Lung Cancer
Diagnostic Assay - Lung Cancer Product Overview
Diagnostic Assay - HER2+/TNBC-Breast Cancer
Diagnostic Assay - HER2+/TNBC-Breast Cancer Product Overview
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis Product Overview
Diagnostic Assay - Melanoma
Diagnostic Assay - Melanoma Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Test - Alzheimer's Disease
Diagnostic Test - Alzheimer's Disease Product Overview
Diagnostic Test - Colon Cancer
Diagnostic Test - Colon Cancer Product Overview
Diagnostic Test - Kidney Damage
Diagnostic Test - Kidney Damage Product Overview
EndoPredict Test
EndoPredict Test Product Overview
HRD Companion Diagnostic Test - Breast Cancer
HRD Companion Diagnostic Test - Breast Cancer Product Overview
Kidney Transplant Rejection Test
Kidney Transplant Rejection Test Product Overview
Multi-Biomarker Test - Ankylosing Spondylitis
Multi-Biomarker Test - Ankylosing Spondylitis Product Overview
Multi-Biomarker Test - Autoimmune Diseases
Multi-Biomarker Test - Autoimmune Diseases Product Overview
Multi-Biomarker Test - Inflammatory Diseases
Multi-Biomarker Test - Inflammatory Diseases Product Overview
Multi-Biomarker Test - Psoriatic Arthritis
Multi-Biomarker Test - Psoriatic Arthritis Product Overview
Multi-Biomarker Test - Systemic Lupus Erythematosus
Multi-Biomarker Test - Systemic Lupus Erythematosus Product Overview
myChoice Diabetes
myChoice Diabetes Product Overview
myChoice HRD (PARP) - Niraparib
myChoice HRD (PARP) - Niraparib Product Overview
myChoice HRD (PARP) - Talazoparib
myChoice HRD (PARP) - Talazoparib Product Overview
myChoice HRD (Platinum)
myChoice HRD (Platinum) Product Overview
myPath BiPolar
myPath BiPolar Product Overview
myPath Endometriosis
myPath Endometriosis Product Overview
myPath Melanoma
myPath Melanoma Product Overview
myPath Pancreatic Cancer
myPath Pancreatic Cancer Product Overview
myPath Prostate Cancer
myPath Prostate Cancer Product Overview
myPath Psoriatic Arthritis
myPath Psoriatic Arthritis Product Overview
myPlan Lung Cancer
myPlan Lung Cancer Product Overview
myPlan Lung Cancer Clinical Trial
myPlan Renal Cancer
myPlan Renal Cancer Product Overview
myRisk Hereditary Cancer
myRisk Hereditary Cancer Product Overview
myRisk Hereditary Cancer Clinical Trial
myRisk Schizophrenia
myRisk Schizophrenia Product Overview
Prognostic Test - Bladder Cancer
Prognostic Test - Bladder Cancer Product Overview
Prolaris
Prolaris Product Overview
Prolaris Clinical Trial
SanoPredict
SanoPredict Product Overview
Tumor BRACAnalysis CDx - Niraparib
Tumor BRACAnalysis CDx - Niraparib Product Overview
Tumor BRACAnalysis CDx - Veliparib
Tumor BRACAnalysis CDx - Veliparib Product Overview
Myriad Genetics Inc - Key Competitors
Myriad Genetics Inc - Key Employees
Myriad Genetics Inc - Key Employee Biographies
Myriad Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Myriad Genetics Inc, Recent Developments
Dec 27, 2016: Positive Clinical Utility Results of Crescendo’s Vectra DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology
Dec 22, 2016: United Rheumatology Issues Clinical Practice Guidelines and Recommends the Vectra DA Test for Adults with Rheumatoid Arthritis
Dec 09, 2016: The EndoPredict Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence
Nov 28, 2016: Myriad Genetics To Present Breast Cancer Studies on myChoice HRD at SABCS
Nov 28, 2016: Myriad Genetics To Present Breast Cancer Studies On myRisk Hereditary Cancer at SABCS
Nov 28, 2016: Myriad Genetics to Present New Data on EndoPredict at SABCS
Nov 12, 2016: Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting
Nov 07, 2016: Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx
Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results
Oct 27, 2016: The Myriad myPath Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Myriad Genetics Inc Pipeline Products and Clinical Trials Overview
Myriad Genetics Inc Pipeline Products by Equipment Type
Myriad Genetics Inc Pipeline Products by Indication
Myriad Genetics Inc Clinical Trials by Trial Status
Myriad Genetics Inc, Key Facts
Myriad Genetics Inc, Major Products and Services
Myriad Genetics Inc Number of Pipeline Products by Development Stage
Myriad Genetics Inc Pipeline Products Summary by Development Stage
Myriad Genetics Inc Clinical Trials by Trial Status
Myriad Genetics Inc Clinical Trials Summary
BRACAnalysis CDx - Breast Cancer - Product Status
BRACAnalysis CDx - Breast Cancer - Product Description
BRACAnalysis CDx - Ovarian Cancer - Product Status
BRACAnalysis CDx - Ovarian Cancer - Product Description
BRACAnalysis CDx - Pancreatic Cancer - Product Status
BRACAnalysis CDx - Pancreatic Cancer - Product Description
ChemoPredict Test - Product Status
ChemoPredict Test - Product Description
Diagnostic Assay - Lung Cancer - Product Status
Diagnostic Assay - Lung Cancer - Product Description
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Status
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Description
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Status
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Description
Diagnostic Assay - Melanoma - Product Status
Diagnostic Assay - Melanoma - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Test - Alzheimer's Disease - Product Status
Diagnostic Test - Alzheimer's Disease - Product Description
Diagnostic Test - Colon Cancer - Product Status
Diagnostic Test - Colon Cancer - Product Description
Diagnostic Test - Kidney Damage - Product Status
Diagnostic Test - Kidney Damage - Product Description
EndoPredict Test - Product Status
EndoPredict Test - Product Description
HRD Companion Diagnostic Test - Breast Cancer - Product Status
HRD Companion Diagnostic Test - Breast Cancer - Product Description
Kidney Transplant Rejection Test - Product Status
Kidney Transplant Rejection Test - Product Description
Multi-Biomarker Test - Ankylosing Spondylitis - Product Status
Multi-Biomarker Test - Ankylosing Spondylitis - Product Description
Multi-Biomarker Test - Autoimmune Diseases - Product Status
Multi-Biomarker Test - Autoimmune Diseases - Product Description
Multi-Biomarker Test - Inflammatory Diseases - Product Status
Multi-Biomarker Test - Inflammatory Diseases - Product Description
Multi-Biomarker Test - Psoriatic Arthritis - Product Status
Multi-Biomarker Test - Psoriatic Arthritis - Product Description
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description
myChoice Diabetes - Product Status
myChoice Diabetes - Product Description
myChoice HRD (PARP) - Niraparib - Product Status
myChoice HRD (PARP) - Niraparib - Product Description
myChoice HRD (PARP) - Talazoparib - Product Status
myChoice HRD (PARP) - Talazoparib - Product Description
myChoice HRD (Platinum) - Product Status
myChoice HRD (Platinum) - Product Description
myPath BiPolar - Product Status
myPath BiPolar - Product Description
myPath Endometriosis - Product Status
myPath Endometriosis - Product Description
myPath Melanoma - Product Status
myPath Melanoma - Product Description
myPath Pancreatic Cancer - Product Status
myPath Pancreatic Cancer - Product Description
myPath Prostate Cancer - Product Status
myPath Prostate Cancer - Product Description
myPath Psoriatic Arthritis - Product Status
myPath Psoriatic Arthritis - Product Description
myPlan Lung Cancer - Product Status
myPlan Lung Cancer - Product Description
myPlan Lung Cancer - Lung CancerRegistry: An Open Registry to Measure the Impact of Adding RNA Expression Testing (myPlan Lung Cancer) on Referral Decisions and to Assess Disease-free Survival With Long-term Follow-up in Newly Diagnosed Early Stage Lung Adenocarcinoma Patients
myPlan Lung Cancer - LUNG CancerRegistry: An Open Registry to Measure the Impact of Adding RNA Expression Testing (myPlan Lung Cancer) on Treatment Decisions and to Assess Disease-free Survival with Long-term Follow-up in Newly Diagnosed Early Stage Lung Adenocarcinoma Patients (LUNG CARE Registry)
myPlan Renal Cancer - Product Status
myPlan Renal Cancer - Product Description
myRisk Hereditary Cancer - Product Status
myRisk Hereditary Cancer - Product Description
myRisk Hereditary Cancer - University of Southern California (USC) Norris Comprehensive Cancer Center and Stanford Cancer Institute Cancer Genetics Hereditary Cancer Panel Testing
myRisk Schizophrenia - Product Status
myRisk Schizophrenia - Product Description
Prognostic Test - Bladder Cancer - Product Status
Prognostic Test - Bladder Cancer - Product Description
Prolaris - Product Status
Prolaris - Product Description
Prolaris - An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients at Intermountain Hospitals
Prolaris - An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients by Specialists
SanoPredict - Product Status
SanoPredict - Product Description
Tumor BRACAnalysis CDx - Niraparib - Product Status
Tumor BRACAnalysis CDx - Niraparib - Product Description
Tumor BRACAnalysis CDx - Veliparib - Product Status
Tumor BRACAnalysis CDx - Veliparib - Product Description
Myriad Genetics Inc, Key Employees
Myriad Genetics Inc, Key Employee Biographies
Myriad Genetics Inc, Subsidiaries
List of Figures
Myriad Genetics Inc Pipeline Products by Equipment Type
Myriad Genetics Inc Pipeline Products by Development Stage
Myriad Genetics Inc Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report